|
|
Academic ServiceUpdated: 07-15-26
View
View
View
View
View
View
View
View
IPE Assignment
| Date: | 07/14/2026 |
| Rotation Type: | APPE Ambulatory Care |
| Comments: | |
| 1. Who was part of the inter-professional rounding team? Is your preceptor involved?: | The interprofessional healthcare team included physician assistants, nurse practitioners/APRNs, NP residents, physicians, nurses, and pharmacy personnel. My pharmacist preceptor supervised my participation and was available to review medication-related questions or recommendations before I communicated them to another healthcare provider. |
| 2. What was your role in the interprofessional team?: | My role was primarily as a student pharmacist observing the physician assistant and APRN/NP residents during patient-care activities. I reviewed patient medication profiles, laboratory results, allergies, potential drug interactions, and medication doses. I also discussed possible medication-related concerns with my pharmacist preceptor before sharing them with the healthcare team. |
| 3. List at least two contributions/recommendations that you made on rounds and how they served to acheived shared goals of the team. Be sure to receive preceptor approval prior to making your recommendations. Were your recommendations accepted by the team?: | Although I was shadowing and did not participate in formal rounds, I contributed during patient-care discussions after reviewing my recommendations with my pharmacist preceptor. First, I reviewed a patient's medication list for polypharmacy, potential drug-drug interactions, and allergy-related concerns. This helped promote medication safety and reduced the risk of preventable adverse effects.Second, I identified a concern regarding the appropriateness of a patient's celecoxib dose and discussed a possible dose adjustment with my preceptor. After receiving my preceptor's approval, the concern was communicated to the healthcare provider. The recommendations were accepted and considered as part of the patient's treatment plan. |
| 4. Write 3-5 activities/roles between the different health care providers that impacted the ultimate patient-care decision.: | The physician assistant and APRN/NP residents collected the patient's history, performed physical examinations, reviewed diagnostic results, and developed the initial assessment and treatment plan. The physician supervised the overall medical plan, confirmed diagnoses, and made final decisions regarding treatment and disposition. Nurses monitored vital signs, administered medications, documented the patient's response to treatment, and communicated changes in the patient's condition. The pharmacist and student pharmacist reviewed medication appropriateness, doses, allergies, drug interactions, renal function, and possible adverse effects. Case managers and other support staff helped coordinate discharge planning, follow-up care, medication access, and communication with outpatient providers. |
| 1. What profession did you shadow?: | I shadowed physician assistants and advanced practice registered nurses, including nurse practitioners and NP residents, during their patient-care activities. |
| 2. List 3-5 activities the other health care professional does to impact patient care.: | Obtain the patient's medical history and perform physical examinations. Review laboratory results, imaging studies, vital signs, and other diagnostic information. Develop differential diagnoses and create individualized treatment plans. Order medications, laboratory tests, imaging studies, and consultations when appropriate. Educate patients about their diagnoses, medications, follow-up appointments, and discharge instructions. |
| 7. Could this provider be benefited from direct involvement of a pharmacist on a consistant basis? If so and you were working here, list the steps would take to propose this change.: | Yes. Physician assistants and nurse practitioners could benefit from having a pharmacist consistently involved in patient care. A pharmacist could assist with medication reconciliation, renal dose adjustments, drug interactions, allergy verification, antimicrobial selection, anticoagulation management, and medication education. I would first discuss the idea with my pharmacist preceptor and gather examples of medication-related interventions that improved patient care. I would then present the proposal to the healthcare team and department leadership, explaining how pharmacist involvement could improve medication safety and efficiency. I would recommend beginning with a pilot program in which a pharmacist regularly reviews medication profiles or participates in patient-care discussions. The team could then track accepted interventions, prevented medication errors, and provider satisfaction to determine the program's value. |
| 8. List at least one contribution you made which assisted the health care professional in their delivery of patient care. Remember if a pharmacy question comes up, always clear your answer with your preceptor first prior to responding if you are unsure the answer.: | I assisted the healthcare provider by reviewing a patient's medication profile for polypharmacy, drug-drug interactions, allergies, and dose appropriateness. I identified a concern involving the patient's celecoxib dose and discussed it with my pharmacist preceptor before communicating it to the provider. This contribution helped support safer and more appropriate medication therapy. |
IPE Assignment
| Date: | 06/02/2026 |
| Rotation Type: | APPE General Medicine |
| Comments: | |
| 1. Who was part of the inter-professional rounding team? Is your preceptor involved?: | The interprofessional team included the attending physician, medical residents/interns, medical students, clinical pharmacist/preceptor, student pharmacist. Yes, my preceptor was involved in the patient-care process and provided clinical pharmacy support by reviewing medication therapy, identifying medication-related problems, assessing renal dosing, monitoring labs, evaluating drug interactions, and making evidence-based recommendations to optimize patient outcomes. |
| 2. What was your role in the interprofessional team?: | My role as a student pharmacist was to actively participate in the patient-care process under the supervision of my preceptor. I reviewed patient charts, medication profiles, laboratory values, cultures, renal function, allergies, and relevant clinical notes before discussing patients with the team. I helped identify medication-related concerns, prepared pharmacy recommendations, and discussed them with my preceptor prior to presenting them to the team. I also listened to the medical team's goals for each patient and contributed from a pharmacy perspective to support safe, effective, and individualized medication therapy. This experience allowed me to be a useful part of the team by helping improve medication safety, supporting evidence-based decisions, and assisting with therapeutic optimization. |
| 3. List at least two contributions/recommendations that you made on rounds and how they served to acheived shared goals of the team. Be sure to receive preceptor approval prior to making your recommendations. Were your recommendations accepted by the team?: | During interprofessional rounds, I actively reviewed patients' medication profiles, allergies, laboratory values, renal function, and overall pharmacotherapy plans under the supervision of my preceptor. Before presenting any recommendation to the medical team, I discussed my findings with my preceptor and received approval. One important contribution I made was identifying potential drug-drug interactions and polypharmacy concerns in a patient who was receiving multiple medications. I reviewed the medication list for duplicate therapy, possible interactions, allergy-related concerns, and medications that could increase the risk of adverse effects. After discussing this with my preceptor, I brought the concern to the team. This helped support the shared goal of improving medication safety, reducing unnecessary medication burden, and preventing avoidable adverse drug events. The recommendation was accepted and considered in the patient's care plan. Another recommendation I made involved Celebrex/celecoxib therapy, where I identified that the patient may benefit from a dose adjustment based on patient-specific factors and safety considerations. After reviewing the indication, dose, patient history, allergy profile, and potential risk factors with my preceptor, I recommended adjusting the dose to a safer and more appropriate regimen. This supported the team's shared goal of providing effective pain/inflammation management while minimizing the risk of medication-related harm. The recommendation was accepted by the team. Overall, my contributions helped the team optimize medication therapy, address safety concerns, and make more individualized patient-care decisions. |
| 4. Write 3-5 activities/roles between the different health care providers that impacted the ultimate patient-care decision.: | Physicians and residents evaluated the patient's diagnosis, clinical status, imaging, laboratory results, and overall treatment plan. They led the discussion regarding the patient's medical problems and daily goals of care. The clinical pharmacist/preceptor reviewed medication therapy for appropriateness, dosing, renal/hepatic adjustment, drug interactions, contraindications, antimicrobial stewardship, anticoagulation safety, and monitoring parameters. Nursing staff provided essential bedside information, including changes in symptoms, medication administration issues, pain control, vital signs, intake/output, patient tolerance of therapy, and any barriers to care. Case management and social work helped assess discharge planning needs, insurance barriers, medication access, placement needs, and outpatient follow-up, which directly influenced the feasibility of the treatment plan. Consulting services such as infectious disease, cardiology, nephrology, respiratory therapy, nutrition, or physical therapy contributed specialty recommendations that helped guide the final patient-care decisions. Overall, the collaboration between these health care professionals helped create a more complete and patient-centered plan. My involvement as a student pharmacist added value by supporting medication safety, identifying therapy-related concerns, and helping the team optimize pharmacotherapy under my preceptor's guidance. |
| 1. What profession did you shadow?: | I shadowed an Internal Medicine physician/medical team during patient care activities. This allowed me to observe how physicians evaluate patients, develop assessment and treatment plans, coordinate care with other health care professionals, and make clinical decisions based on patient-specific factors |
| 2. List 3-5 activities the other health care professional does to impact patient care.: | The Internal Medicine physician/team impacted patient care through several important activities: Patient assessment and clinical evaluation: The physician evaluated each patient's presenting symptoms, past medical history, physical exam findings, laboratory results, imaging, and overall clinical status to determine the appropriate diagnosis and treatment plan. Development of individualized treatment plans: The medical team created patient-specific care plans based on the patient's diagnosis, comorbidities, renal/hepatic function, allergies, current medications, and response to therapy. Medication decision-making and therapy monitoring: The physician reviewed medication therapy, assessed the need for continuation, discontinuation, or adjustment of medications, and monitored for safety and effectiveness. Interprofessional communication: The physician communicated with nurses, pharmacists, case managers, social workers, consultants, and other members of the health care team to coordinate patient care and ensure that all aspects of the patient's needs were addressed. Discharge planning and continuity of care: The physician helped determine discharge readiness, reviewed follow-up needs, addressed medication changes, and coordinated with other team members to support a safe transition of care. |
| 7. Could this provider be benefited from direct involvement of a pharmacist on a consistant basis? If so and you were working here, list the steps would take to propose this change.: | Yes, the Internal Medicine team could significantly benefit from direct and consistent pharmacist involvement. Pharmacists can provide valuable support by reviewing medication profiles, identifying drug-drug interactions, addressing polypharmacy, evaluating allergies, optimizing renal/hepatic dosing, supporting antimicrobial stewardship, assisting with anticoagulation management, and improving discharge medication reconciliation. If I were working at this site, I would take the following steps to propose this change: Identify areas where pharmacist involvement would improve patient care: I would collect examples of medication-related interventions, such as dose adjustments, drug interaction prevention, allergy clarification, antimicrobial optimization, anticoagulation monitoring, and reduction of unnecessary medications. Discuss the need with my preceptor and pharmacy leadership: I would first review my observations with my preceptor and seek guidance on how to appropriately present the value of pharmacist involvement to the team. Present the benefits to the medical team: I would explain how consistent pharmacist participation could improve medication safety, reduce adverse drug events, support evidence-based prescribing, improve transitions of care, and help providers manage complex medication regimens more efficiently. Suggest a pilot model: I would recommend starting with pharmacist participation in rounds a few days per week or focusing on high-risk patients, such as those with polypharmacy, renal impairment, complex infections, anticoagulation therapy, diabetes, heart failure, or multiple medication changes. Track outcomes and interventions: I would help document pharmacist recommendations, acceptance rates, medication safety interventions, discharge medication reconciliation improvements, and provider feedback to show the positive impact of pharmacist involvement. Overall, I believe pharmacist involvement would be highly beneficial to the Internal Medicine team by strengthening medication safety, improving therapeutic decision-making, and supporting better patient outcomes. |
| 8. List at least one contribution you made which assisted the health care professional in their delivery of patient care. Remember if a pharmacy question comes up, always clear your answer with your preceptor first prior to responding if you are unsure the answer.: | During this experience, I contributed by reviewing patients' medication profiles, allergy history, and potential medication-related concerns under the supervision of my preceptor. I identified issues such as possible drug-drug interactions, polypharmacy concerns, and the need to evaluate medication appropriateness based on patient-specific factors. One specific contribution involved reviewing a patient's pain management regimen and identifying that Celebrex/celecoxib dosing may need to be adjusted based on the patient's clinical status and safety considerations. I discussed this with my preceptor before communicating the concern. This helped support safer and more appropriate medication use. I also helped by reviewing allergy information and medication histories to assist the medical team in avoiding potential adverse drug events. These contributions supported the Internal Medicine team's delivery of patient care by adding a pharmacy perspective focused on medication safety, appropriate dosing, and optimization of therapy. |
Additional Assignments
| Date: | 07/02/2026 |
| Rotation Type: | APPE Ambulatory Care |
| Comments: | review 550 pt about the baxero vaccine and make this excel sheet |
View
Pharmacist Patient Care Process Model
| Date: | 06/18/2026 |
| Rotation Type: | APPE General Medicine |
| Comments: |
View
Additional Assignments
| Date: | 06/02/2026 |
| Rotation Type: | APPE General Medicine |
| Comments: | Topic Discusion |
View
Pharmacy Student
Over the Counter Patient Education using the Patient Care Process Model (SLO 8) (see attached OTC form)
| Date: | 05/16/2025 |
| Rotation Type: | IPPE Community |
| Comments: | ? |
| Describe any challenges during the encounter?: | The patient was unsure whether they needed a doctor's visit for allergies or if OTC medication was enough. |
| How did you/would you resolve these?: | I explained the criteria for self-care and why their case was appropriate. I reviewed red flag symptoms that would warrant medical evaluation. |
| How would you prevent such challenges in future encounters?: | Provide patients with a clear explanation of when OTC options are appropriate and use visual aids (like signage or printed handouts) to increase understanding. |
View
Pharmacy Student
Pharmacy Student
Interprofessional Education (SLO 6) Encounter #4:
| Date: | 05/09/2025 |
| Rotation Type: | IPPE Community |
| Comments: | ? |
| Were there any challenges during the encounter? And if so, how did you/would you resolve these?: | es, the patient was uncertain about which dose to take and had already started alternating between the two strengths, thinking it was acceptable. How I Resolved It: After confirming the correct dose with the physician, I contacted the patient to explain the correct 75 mcg daily dosing, advised them to stop using the 50 mcg tablets, and clarified the importance of taking the same dose consistently each day. I also ensured the outdated prescription was deactivated in the system to prevent future confusion. |
| What type of prescriber did you speak with (e.g. dentist, podiatrist, physician, nurse practitioner, physician assistant)?: | I spoke with a physician to clarify the duplicate Synthroid prescriptions and confirm the correct dosage |
| What was the issue?: | The patient had two active prescriptions for Synthroid (levothyroxine) at different strengths 50 mcg and 75 mcg both recently filled. This raised a concern for duplicate therapy, which could lead to incorrect dosing and thyroid imbalance. Clarification was needed to determine the correct dose and discontinue the outdated prescription |
| What was the provider's response?: | The physician acknowledged the error and confirmed that the intended dose was 75 mcg daily. They appreciated the clarification, authorized discontinuation of the 50 mcg prescription, and agreed that the patient should be counseled to use only the correct strength moving forward. |
| What were the recommendations?: | I recommended the prescriber discontinue the outdated 50 mcg Synthroid prescription and maintain only the 75 mcg daily dose as the active prescription. I also suggested that the patient be instructed to discard any remaining 50 mcg tablets to avoid confusion and ensure consistent, accurate dosing. |
Pharmacy Student
Interprofessional Education (SLO 6) Encounter #3
| Date: | 05/08/2025 |
| Rotation Type: | IPPE Community |
| Comments: | ? |
| Were there any challenges during the encounter? And if so, how did you/would you resolve these?: | The main challenge was ensuring the urgency of the allergy concern was communicated clearly, especially since the patient was scheduled to receive the medication shortly. How I Resolved It: I clearly stated that the patient had a documented allergy to sulbactam and explained the potential risks if the medication were administered. I also came prepared with a safe alternative (ceftriaxone), which helped the physician make a quick, informed decision. Being concise and respectful helped facilitate a smooth and effective resolution. |
| What type of prescriber did you speak with (e.g. dentist, podiatrist, physician, nurse practitioner, physician assistant)?: | I spoke with a physician to clarify the prescription and address the patient's documented allergy to sulbactam. |
| What was the issue?: | A prescription was received for ampicillin/sulbactam (Unasyn), but the patient had a documented allergy to sulbactam, including symptoms of rash and facial swelling. This raised a safety concern that required clarification with the prescriber before the medication could be administered. |
| What was the provider's response?: | The physician was appreciative of the alert and agreed with the recommendation. They confirmed they were not aware of the sulbactam allergy and promptly changed the order to ceftriaxone to ensure patient safety. |
| What were the recommendations?: | I recommended discontinuing ampicillin/sulbactam due to the documented sulbactam allergy and suggested switching to an appropriate alternative that would provide similar coverage without risk such as ceftriaxone, depending on the infection being treated and the patient's clinical status. |
Pharmacy Student
Interprofessional Education (SLO 6) Encounter #2
| Date: | 05/07/2025 |
| Rotation Type: | IPPE Community |
| Comments: | ? |
| Were there any challenges during the encounter? And if so, how did you/would you resolve these?: | Yes, there was a minor challenge in reaching the prescriber directly. I was initially placed on hold and had to speak with the front desk staff before being transferred to the nurse practitioner. How I Resolved It: I remained patient and professional, clearly explained the reason for the call, and emphasized the importance of ensuring the patient received the correct quantity. Once connected, I quickly summarized the issue, which helped the nurse practitioner provide a prompt and helpful response. |
| What type of prescriber did you speak with (e.g. dentist, podiatrist, physician, nurse practitioner, physician assistant)?: | I spoke with a nurse practitioner to clarify the prescription quantity. |
| What was the issue?: | The prescription for metformin 500 mg was written with directions to take 1 tablet twice daily, but the quantity prescribed was only 30 tablets, which is insufficient for a 30-day supply. Based on the directions, the correct quantity should have been 60 tablets. This discrepancy needed clarification before dispensing to avoid underdosing the patient |
| What was the provider's response?: | The nurse practitioner agreed with the recommendation and confirmed that the intended directions were 1 tablet twice daily. She verbally authorized updating the quantity to 60 tablets and appreciated the clarification to ensure the patient received the correct supply. |
| What were the recommendations?: | I recommended updating the prescription to reflect the correct 30-day supply, which would require 60 tablets based on the directions of 1 tablet twice daily. This adjustment ensures the patient receives the appropriate amount of medication for the prescribed duration. |
Pharmacy Student
Pharmacy Positions in Community Practice (SLO 1)
| Date: | 05/10/2025 |
| Rotation Type: | IPPE Community |
| Comments: | ? |
| How do each of these positions work together to provide patient-centered care?: | Both the pharmacy manager and staff pharmacist are licensed pharmacists. The pharmacy manager handles leadership and operations, while still providing patient care. The staff pharmacist focuses more on daily clinical tasks. Together, they collaborate to ensure efficient workflow and high-quality, patient-centered care |
| List the different pharmacy positions at your community pharmacy practice site (e.g., pharmacist, pharmacist in charge, pharmacy technician) and briefly describe the roles and responsibilities of each position.: | Pharmacy Manager Staff Pharmacist |
Pharmacy Student
Patient Advocacy (SLO 9)
| Date: | 05/10/2025 |
| Rotation Type: | IPPE Community |
| Comments: | ? |
| What specifically did you do to help the patient? (e.g. find a prescription discount card and provide it to the patient, discuss an alternative therapy with your preceptor/the patient's prescriber): | I first verified the rejection reason through the pharmacy system (e.g., refill too soon or non-formulary). Then, I consulted with my preceptor to determine the most appropriate action. Depending on the issue, I: For "too soon to refill": Explained the situation to the patient, reviewed when the medication would be eligible for refill, and discussed temporary options like splitting doses or using leftover supply if available and safe. For non-formulary or not covered: Helped identify a therapeutic alternative that was covered by the patient's insurance and discussed it with the prescriber for a possible switch. For prior authorization needed: Informed the patient about the insurance requirement and guided them to contact their provider's office to start the process, while also checking if a short-term supply or discount program could help in the meantime. |
| Why was the medication not covered by their insurance?: | It's too soon to refill based on the last fill date. The medication is not on the formulary (non-preferred or excluded). It is an over-the-counter (OTC) product not eligible for coverage. Prior authorization is required but not yet approved. The patient must try a lower-cost alternative first (step therapy). It exceeds quantity or frequency limits set by the plan |
Pharmacy Student
Medication Ordering and Inventory Management in the Community Setting (SLO 3)
| Date: | 05/10/2025 |
| Rotation Type: | IPPE Community |
| Comments: | ? |
| Who has primary responsibility for this process?: | pharmacist-in-charge |
| Describe how medications are ordered and how inventory is maintained in the pharmacy department.: | Publix Pharmacy uses an automated system connected with Cardinal Health to manage medication ordering. The system tracks inventory in real time and automatically places orders when stock is low. Pharmacists can manually adjust orders as needed. Controlled substances are ordered separately using DEA-compliant systems like CSOS. Inventory is maintained through daily checks, regular cycle counts, and proper storage, including temperature monitoring for refrigerated items. Expired or damaged medications are returned through Cardinal's reverse distribution process. This system ensures accurate, efficient, and compliant medication management. |
Pharmacy Student
Interprofessional Education (SLO 6) Encounter #1:
| Date: | 05/10/2025 |
| Rotation Type: | IPPE Community |
| Comments: | ? |
| Were there any challenges during the encounter? And if so, how did you/would you resolve these?: | The main challenge was the unusual indication of gabapentin for cough, which required clarification. I addressed this by respectfully contacting the physician, who confirmed the off-label use for chronic refractory cough. We discussed starting at a low dose with close monitoring. The situation was resolved through professional communication, clinical reasoning, and thorough patient counseling. |
| What type of prescriber did you speak with (e.g. dentist, podiatrist, physician, nurse practitioner, physician assistant)?: | I spoke with a physician to clarify the prescription for gabapentin written with the indication "for cough." |
| What was the issue?: | A prescription was received for gabapentin with the indication noted as "for cough," which raised a clinical concern. |
| What was the provider's response?: | The physician acknowledged that the use of gabapentin for cough was off-label but explained that it was intentional and based on the patient's history of chronic refractory cough that had not responded to traditional therapies. He appreciated the pharmacist's diligence in verifying the indication and agreed with the recommendation to start at a low dose and monitor for side effects. The provider also confirmed that he would follow up with the patient in a few weeks to evaluate effectiveness and tolerability |
| What were the recommendations?: | Clarify Indication: Confirmed with the physician that gabapentin was being prescribed off-label for chronic refractory cough with a suspected neuropathic origin. Start at Low Dose: Recommended initiating gabapentin at a low dose (e.g., 100-300 mg at bedtime) to minimize side effects such as drowsiness and dizziness, especially in older adults or those with respiratory issues. |
Pharmacy Student
Immunizations and Preventative Care (SLO 7)
| Date: | 05/10/2025 |
| Rotation Type: | IPPE Community |
| Comments: | ? |
| Review the immunization form your site provides to each patient receiving an influenza immunization or other immunization. Counsel a patient receiving this immunization on this form (e.g. side effects, allergic reactions and associated risks) prior to them receiving the immunization. Describe your patient interactions below, including the side effects you counseled on.: | I counseled a 65-year-old male receiving the Shingrix vaccine for shingles prevention. I explained that it's a 2-dose vaccine series and reviewed common side effects such as injection site pain, fatigue, muscle aches, fever, and chills. I also discussed rare but serious allergic reactions, advised the patient to stay for 15 minutes of observation, and encouraged over-the-counter pain relief if needed. The patient had no contraindications, gave verbal consent, and was reminded to return for his second dose in 2-6 months |
| Shadow your preceptor while he/she administers the immunization. (Note: You are not able to vaccinate patients during IPPE. You must receive an APhA certification and training, which LU COP will provide during your P2 year, prior to APPE). Describe the process you observed, noting any particular use of technique or education provided to the patient (e.g. angle of injection, handling of hazardous waste).: | During my IPPE rotation at Publix Pharmacy, I observed my preceptor administer the Shingrix vaccine to an adult patient. He confirmed the patient's eligibility, reviewed the Vaccine Information Statement (VIS), and obtained informed consent. Using proper aseptic technique, he reconstituted the vaccine and administered it intramuscularly into the deltoid muscle at a 90-degree angle. After the injection, he safely disposed of the needle in a sharps container and provided post-vaccination counseling, including expected side effects and the importance of returning for the second dose. The patient remained in the pharmacy for 15 minutes of observation. This experience highlighted proper technique, patient communication, and safety practices in a community pharmacy setting. |
Pharmacy Student
Database Systems in Community Practice (SLO 2)
| Date: | 05/10/2025 |
| Rotation Type: | IPPE Community |
| Comments: | ? |
| How does this database system alert a pharmacist to medication related problems?: | Drug-drug interaction alerts Allergy and contraindication warnings Duplicate therapy and dose range checks Drug-disease interactions Refill-too-soon notifications Age-specific safety alerts (e.g., for elderly or pediatric patients) |
| Provide an example of how a pharmacist resolved a medication related problem within this system.: | A patient at Publix Pharmacy was prescribed clarithromycin while already taking simvastatin. When the pharmacist entered the prescription into EnterpriseRx, the system generated a drug-drug interaction alert, warning of a risk for rhabdomyolysis due to CYP3A4 inhibition by clarithromycin. The pharmacist: Reviewed the interaction details in the system. Contacted the prescriber to discuss safer alternatives. Recommended switching to azithromycin, which does not inhibit CYP3A4. Documented the intervention in the system. The prescriber approved the change, and the patient received the safer antibiotic, avoiding potential harm. |
| What is the name of the database system your community pharmacy practice site uses to process prescription orders?: | Publix Pharmacy utilizes EnterpriseRx, a cloud-based pharmacy management system developed by McKesson, to process prescription orders. |
Database Systems in Community Practice (SLO 2)
| Date: | 05/10/2025 |
| Rotation Type: | IPPE Community |
| Comments: | ? |
| How does this database system alert a pharmacist to medication related problems?: | rug-drug interaction alerts Allergy and contraindication warnings Duplicate therapy and dose range checks Drug-disease interactions Refill-too-soon notifications Age-specific safety alerts (e.g., for elderly or pediatric patients) |
| Provide an example of how a pharmacist resolved a medication related problem within this system.: | A patient at Publix Pharmacy was prescribed clarithromycin while already taking simvastatin. When the pharmacist entered the prescription into EnterpriseRx, the system generated a drug-drug interaction alert, warning of a risk for rhabdomyolysis due to CYP3A4 inhibition by clarithromycin. The pharmacist: Reviewed the interaction details in the system. Contacted the prescriber to discuss safer alternatives. Recommended switching to azithromycin, which does not inhibit CYP3A4. Documented the intervention in the system. The prescriber approved the change, and the patient received the safer antibiotic, avoiding potential harm. |
| What is the name of the database system your community pharmacy practice site uses to process prescription orders?: | Publix Pharmacy utilizes EnterpriseRx, a cloud-based pharmacy management system developed by McKesson, to process prescription orders. |
Database Systems in Community Practice (SLO 2)
| Date: | 05/10/2025 |
| Rotation Type: | IPPE Community |
| Comments: | ? |
| How does this database system alert a pharmacist to medication related problems?: | Drug-drug interaction alerts Allergy and contraindication warnings Duplicate therapy and dose range checks Drug-disease interactions Refill-too-soon notifications Age-specific safety alerts (e.g., for elderly or pediatric patients) |
| Provide an example of how a pharmacist resolved a medication related problem within this system.: | A patient at Publix Pharmacy was prescribed clarithromycin while already taking simvastatin. When the pharmacist entered the prescription into EnterpriseRx, the system generated a drug-drug interaction alert, warning of a risk for rhabdomyolysis due to CYP3A4 inhibition by clarithromycin. The pharmacist: Reviewed the interaction details in the system. Contacted the prescriber to discuss safer alternatives. Recommended switching to azithromycin, which does not inhibit CYP3A4. Documented the intervention in the system. The prescriber approved the change, and the patient received the safer antibiotic, avoiding potential harm. |
| What is the name of the database system your community pharmacy practice site uses to process prescription orders?: | Publix Pharmacy utilizes EnterpriseRx, a cloud-based pharmacy management system developed by McKesson, to process prescription orders. |
IPPE Institutional Checklist
| Date: | 04/18/2025 |
| Rotation Type: | IPPE Institutional/Hospital Practice |
| Comments: | File attached. |
View
Calculations (SLO 9)
| Date: | 04/18/2025 |
| Rotation Type: | IPPE Institutional/Hospital Practice |
| Comments: | File attached |
View
Calculations (SLO 9)
| Date: | 04/18/2025 |
| Rotation Type: | IPPE Institutional/Hospital Practice |
| Comments: | ? |
View
Calculations (SLO 9)
| Date: | 04/18/2025 |
| Rotation Type: | IPPE Institutional/Hospital Practice |
| Comments: | ? |
View
Pharmacy Student
Medication Related Policies and Procedures (SLO 5)
| Date: | 04/16/2025 |
| Rotation Type: | IPPE Institutional/Hospital Practice |
| Comments: | ? |
| Select a particular medication related policy at your particular institution. Interview your preceptor and identify how the policy was created, approved, and implemented.: | Policy: Therapeutic Interchange for Proton Pump Inhibitors (PPIs) Institution: Larkin Community Hospital I interviewed my preceptor about the PPI Therapeutic Interchange Policy, which allows pharmacists to substitute non-formulary PPIs with formulary options (e.g., substituting pantoprazole with omeprazole) without needing a new physician order. Creation: The pharmacy team identified frequent non-formulary PPI use and proposed the policy based on cost savings and clinical equivalence. Approval: The draft policy was reviewed by the Pharmacy & Therapeutics (P&T) Committee, revised, and approved by hospital administration. Implementation: The EMR was updated, staff were educated, and pharmacists were trained to apply the policy and document substitutions. |
Medication Related Policies and Procedures (SLO 5)
| Date: | 04/16/2025 |
| Rotation Type: | IPPE Institutional/Hospital Practice |
| Comments: | ? |
| Select a particular medication related policy at your particular institution. Interview your preceptor and identify how the policy was created, approved, and implemented.: |
Policy: Therapeutic Interchange for Proton Pump Inhibitors (PPIs) ?Institution: Larkin Community Hospital I interviewed my preceptor about the PPI Therapeutic Interchange Policy, which allows pharmacists to substitute non-formulary PPIs with formulary options (e.g., substituting pantoprazole with omeprazole) without needing a new physician order. Creation: The pharmacy team identified frequent non-formulary PPI use and proposed the policy based on cost savings and clinical equivalence. ?Approval: The draft policy was reviewed by the Pharmacy & Therapeutics (P&T) Committee, revised, and approved by hospital administration. ?Implementation: The EMR was updated, staff were educated, and pharmacists were trained to apply the policy and document substitutions. |
Pharmacy Student
Pharmacy Positions in Institutional/Health System (SLO 1)
| Date: | 04/09/2025 |
| Rotation Type: | IPPE Institutional/Hospital Practice |
| Comments: | Pharmacy Positions in Institutional/Health System (SLO 1) |
| How do each of these positions work together to provide patient-centered care?: | At our institution, daily huddle meetings bring together all pharmacy team members to align on priorities and ensure safe, effective, and patient-focused care. |
| List the different pharmacy positions at your hospital pharmacy practice site (e.g., manager, pharmacist, specialty pharmacist, medication safety officer, director of pharmacy, pharmacy technician) and briefly describe the roles and responsibilities of each position.: | 1-Pharmacy Director - Oversees the entire pharmacy department, including staffing, budgeting, operations, and compliance with regulations. 2-Clinical Pharmacy Manager - Manages the clinical pharmacy services, oversees controlled substances, and ensures adherence to clinical protocols and safety standards. 3-Clinical Pharmacist Specialist - Reviews patient profiles, participates in interdisciplinary rounds, and provides consultations and therapeutic recommendations. 4-General Pharmacist - Reviews medication orders and dosages, verifies appropriateness, and ensures medications are safe and effective for dispensing. 5-Pharmacy Resident (PGY1) - Participates in rounds, reviews patients' medication regimens, adjusts dosages, and engages in educational activities like journal clubs. 6-Lead Pharmacy Technician - Supervises pharmacy technicians, manages schedules, coordinates workflow, and ensures daily operations run smoothly. 7-Compounding Pharmacy Technician - Prepares sterile and non-sterile compounded medications, following strict protocols for safety and accuracy. 8-Pharmacy Technician - Handles medication filling, inventory checks, answers phone calls, and delivers medications to the appropriate units. |
Pharmacy Positions in Institutional/Health System (SLO 1)
| Date: | 04/09/2025 |
| Rotation Type: | IPPE Institutional/Hospital Practice |
| Comments: | Pharmacy Positions in Institutional/Health System (SLO 1) |
| How do each of these positions work together to provide patient-centered care?: | At our institution, daily huddle meetings bring together all pharmacy team members to align on priorities and ensure safe, effective, and patient-focused care. |
| List the different pharmacy positions at your hospital pharmacy practice site (e.g., manager, pharmacist, specialty pharmacist, medication safety officer, director of pharmacy, pharmacy technician) and briefly describe the roles and responsibilities of each position.: |
1-Pharmacy Director - Oversees the entire pharmacy department, including staffing, budgeting, operations, and compliance with regulations. ?2-Clinical Pharmacy Manager - Manages the clinical pharmacy services, oversees controlled substances, and ensures adherence to clinical protocols and safety standards. ?3-Clinical Pharmacist Specialist - Reviews patient profiles, participates in interdisciplinary rounds, and provides consultations and therapeutic recommendations. ?4-General Pharmacist - Reviews medication orders and dosages, verifies appropriateness, and ensures medications are safe and effective for dispensing. ?5-Pharmacy Resident (PGY1) - Participates in rounds, reviews patients' medication regimens, adjusts dosages, and engages in educational activities like journal clubs. ?6-Lead Pharmacy Technician - Supervises pharmacy technicians, manages schedules, coordinates workflow, and ensures daily operations run smoothly. 7-Compounding Pharmacy Technician - Prepares sterile and non-sterile compounded medications, following strict protocols for safety and accuracy. 8-Pharmacy Technician - Handles medication filling, inventory checks, answers phone calls, and delivers medications to the appropriate units. |
Pharmacy Student
Medication Process in an Institutional/Health System Setting (SLO 3)
| Date: | 04/09/2025 |
| Rotation Type: | IPPE Institutional/Hospital Practice |
| Comments: | Medication Process in an Institutional/Health System Setting ?(SLO 3) |
| Explain how a medication is verified, checked, and sorted for floor delivery.: | Pharmacy Technician - Locates the correct medication and dose as per the order - Checks the expiration date - Prepares and applies the appropriate label - Passes the medication to the pharmacist for verification Pharmacist - Reviews the order for accuracy and safety - Verifies the patient's information, medication name, dose, form, quantity, administration time, and date - Ensures the order is clinically appropriate and safe for the patient - Once verified, signs or initials the label - Returns the medication to the pharmacy technician Pharmacy Technician - Delivers the verified medication to the patient or the appropriate care unit |
| Explain the process of what happens to a medication once it leaves the pharmacy. How is the medication delivered to the floor, stored prior to administration (e.g. Pyxis, Omnicell), and ultimately administered to the patient.: | After the pharmacist verifies and signs off on the medication: The pharmacy technician ensures that patient information is kept confidential during transport, in compliance with HIPAA regulations. Upon arriving at the ward, the technician locates the nurse in charge of the patient. The medication is handed directly to the nurse, and the technician requests a signature on the delivery confirmation sheet to document that the medication was received. Alternatively, if applicable, the medication may be placed in the Pyxis system under the specific patient's profile for secure and documented storage until administration |
| What are the 5 Rights of drug administration?: | 1-Right Patient - Confirm the identity of the correct patient using at least two identifiers (e.g., name and date of birth). 2-Right Drug - Ensure the correct medication is being administered, matching the order exactly. 3-Right Dose - Verify the correct dosage based on the order, patient-specific factors, and clinical guidelines. 4-Right Route - Confirm the proper method of administration (e.g., oral, IV, IM, subcutaneous). 5-Right Time - Administer the medication at the correct time and frequency, considering scheduled dosing and clinical timing requirements |
Medication Process in an Institutional/Health System Setting (SLO 3)
| Date: | 04/09/2025 |
| Rotation Type: | IPPE Institutional/Hospital Practice |
| Comments: | Medication Process in an Institutional/Health System Setting ?(SLO 3) |
| Explain how a medication is verified, checked, and sorted for floor delivery.: | Pharmacy Technician - Locates the correct medication and dose as per the order - Checks the expiration date - Prepares and applies the appropriate label - Passes the medication to the pharmacist for verification Pharmacist - Reviews the order for accuracy and safety - Verifies the patient's information, medication name, dose, form, quantity, administration time, and date - Ensures the order is clinically appropriate and safe for the patient - Once verified, signs or initials the label - Returns the medication to the pharmacy technician Pharmacy Technician - Delivers the verified medication to the patient or the appropriate care unit |
| Explain the process of what happens to a medication once it leaves the pharmacy. How is the medication delivered to the floor, stored prior to administration (e.g. Pyxis, Omnicell), and ultimately administered to the patient.: | After the pharmacist verifies and signs off on the medication: The pharmacy technician ensures that patient information is kept confidential during transport, in compliance with HIPAA regulations. Upon arriving at the ward, the technician locates the nurse in charge of the patient. The medication is handed directly to the nurse, and the technician requests a signature on the delivery confirmation sheet to document that the medication was received. Alternatively, if applicable, the medication may be placed in the Pyxis system under the specific patient's profile for secure and documented storage until administration |
| What are the 5 Rights of drug administration?: | 1-Right Patient - Confirm the identity of the correct patient using at least two identifiers (e.g., name and date of birth). 2-Right Drug - Ensure the correct medication is being administered, matching the order exactly. 3-Right Dose - Verify the correct dosage based on the order, patient-specific factors, and clinical guidelines. 4-Right Route - Confirm the proper method of administration (e.g., oral, IV, IM, subcutaneous). 5-Right Time - Administer the medication at the correct time and frequency, considering scheduled dosing and clinical timing requirements |
Medication Process in an Institutional/Health System Setting (SLO 3)
| Date: | 04/09/2025 |
| Rotation Type: | IPPE Institutional/Hospital Practice |
| Comments: | ? |
| Explain how a medication is verified, checked, and sorted for floor delivery.: | Pharmacy Technician - Locates the correct medication and dose as per the order - Checks the expiration date - Prepares and applies the appropriate label - Passes the medication to the pharmacist for verification Pharmacist - Reviews the order for accuracy and safety - Verifies the patient's information, medication name, dose, form, quantity, administration time, and date - Ensures the order is clinically appropriate and safe for the patient - Once verified, signs or initials the label - Returns the medication to the pharmacy technician Pharmacy Technician - Delivers the verified medication to the patient or the appropriate care unit |
| Explain the process of what happens to a medication once it leaves the pharmacy. How is the medication delivered to the floor, stored prior to administration (e.g. Pyxis, Omnicell), and ultimately administered to the patient.: | After the pharmacist verifies and signs off on the medication: The pharmacy technician ensures that patient information is kept confidential during transport, in compliance with HIPAA regulations. Upon arriving at the ward, the technician locates the nurse in charge of the patient. The medication is handed directly to the nurse, and the technician requests a signature on the delivery confirmation sheet to document that the medication was received. Alternatively, if applicable, the medication may be placed in the Pyxis system under the specific patient's profile for secure and documented storage until administration |
| What are the 5 Rights of drug administration?: | 1-Right Patient - Confirm the identity of the correct patient using at least two identifiers (e.g., name and date of birth). 2-Right Drug - Ensure the correct medication is being administered, matching the order exactly. 3-Right Dose - Verify the correct dosage based on the order, patient-specific factors, and clinical guidelines. 4-Right Route - Confirm the proper method of administration (e.g., oral, IV, IM, subcutaneous). 5-Right Time - Administer the medication at the correct time and frequency, considering scheduled dosing and clinical timing requirements |
Medication Process in an Institutional/Health System Setting (SLO 3)
| Date: | 04/09/2025 |
| Rotation Type: | IPPE Institutional/Hospital Practice |
| Comments: | Medication Process in an Institutional/Health System Setting ?(SLO 3) |
| Explain how a medication is verified, checked, and sorted for floor delivery.: | Pharmacy Technician - Locates the correct medication and dose as per the order - Checks the expiration date - Prepares and applies the appropriate label - Passes the medication to the pharmacist for verification Pharmacist - Reviews the order for accuracy and safety - Verifies the patient's information, medication name, dose, form, quantity, administration time, and date - Ensures the order is clinically appropriate and safe for the patient - Once verified, signs or initials the label - Returns the medication to the pharmacy technician Pharmacy Technician - Delivers the verified medication to the patient or the appropriate care unit |
| Explain the process of what happens to a medication once it leaves the pharmacy. How is the medication delivered to the floor, stored prior to administration (e.g. Pyxis, Omnicell), and ultimately administered to the patient.: | After the pharmacist verifies and signs off on the medication: The pharmacy technician ensures that patient information is kept confidential during transport, in compliance with HIPAA regulations. Upon arriving at the ward, the technician locates the nurse in charge of the patient. The medication is handed directly to the nurse, and the technician requests a signature on the delivery confirmation sheet to document that the medication was received. Alternatively, if applicable, the medication may be placed in the Pyxis system under the specific patient's profile for secure and documented storage until administration |
| What are the 5 Rights of drug administration?: | 1-Right Patient - Confirm the identity of the correct patient using at least two identifiers (e.g., name and date of birth). 2-Right Drug - Ensure the correct medication is being administered, matching the order exactly. 3-Right Dose - Verify the correct dosage based on the order, patient-specific factors, and clinical guidelines. 4-Right Route - Confirm the proper method of administration (e.g., oral, IV, IM, subcutaneous). 5-Right Time - Administer the medication at the correct time and frequency, considering scheduled dosing and clinical timing requirements |
Medication Information Sources (SLO 7)
| Date: | 04/01/2025 |
| Rotation Type: | IPPE Institutional/Hospital Practice |
| Comments: | Medication Information Sources (SLO 7) |
| Interview your preceptor and identify 3 medication resources that they use on a frequent basis. What are they?: | 1-Lexicomp 2-UpToDate 3-Epocrates |
| Where do you go to access each of these 3 resources at this institution?: | Internet Mobile App. |
Medication Information Sources (SLO 7)
| Date: | 04/01/2025 |
| Rotation Type: | IPPE Institutional/Hospital Practice |
| Comments: | Medication Information Sources (SLO 7) |
| Interview your preceptor and identify 3 medication resources that they use on a frequent basis. What are they?: |
1-Lexicomp ?2-UpToDate ?3-Epocrates |
| Where do you go to access each of these 3 resources at this institution?: |
Internet ?Mobile App. |
Interprofessional Exposure (SLO 6) Option 2
| Date: | 04/01/2025 |
| Rotation Type: | IPPE Institutional/Hospital Practice |
| Comments: | Interprofessional Exposure (SLO 6) Option 2 |
| Could this provider be benefited from a pharmacist's direct involvement? If so, how?: | Yes. For example, during rounds, the pharmacist identified that the patient's orthostatic hypotension was likely caused by one of the medications they were taking. This led to a timely adjustment in therapy, improving the patient's hemodynamic stability and preventing further complications. This illustrates how a pharmacist's direct involvement can enhance medication safety, support clinical decision-making, and contribute to better patient outcomes |
| How did these activities impact pharmacy?: | Improved Clinical Insight - Physicians and nurses provide essential updates that help pharmacists make safer, more accurate medication recommendations. Collaborative Decision-Making - Real-time discussion during rounds allows pharmacists to adjust or optimize therapy on the spot, reinforcing their role in patient care. Enhanced Interprofessional Communication - Clear communication from the team ensures pharmacy is aligned with the care plan, improving efficiency and patient outcomes. |
| List at least 3 activities the other health care professional performs that impact patient care.: | 1-Physician (Internist/Resident): - Formulates and updates the care plan based on physical exams, labs, and imaging; adjusts treatment accordingly to address acute issues and chronic disease management. 2-Nurse: - Provides real-time updates on the patient's condition, including vital signs, fluid balance, pain levels, and responses to medications-helping guide immediate clinical decisions. 3-Medical Student: - Presents thorough patient histories and assessments, contributing to differential diagnoses and offering evidence-based suggestions that enrich team discussions and planning. |
| What profession did you shadow?: | Clinical Pharmacist Specialist |
Pharmacy Student
Interprofessional Exposure (SLO 6) Option 1
| Date: | 04/01/2025 |
| Rotation Type: | IPPE Institutional/Hospital Practice |
| Comments: | Interprofessional Exposure (SLO 6) Option 1 |
| Describe how the pharmacist contributed to rounds. If a pharmacist is not part of the rounding team, describe how the team could have benefited from a pharmacist's direct involvement.: | The clinical pharmacist played a vital role during rounds by providing real-time input on medication management and patient safety. They reviewed each patient's active medication list, identified potential drug interactions and duplicative therapies, and made recommendations to optimize dosing, especially in the context of renal and hepatic function. Their involvement significantly enhanced medication reconciliation, promoted evidence-based therapy, and supported interdisciplinary decision-making. |
| List all professions who were part of the interprofessional rounding team. Is your preceptor involved?: |
-Attending Internist ?IM Chief Resident IM PGY-2 IM PGY-1 Clinical Pharmacist ?Pharmacist Intern ?Medical Student |
| List at least 3 activities that occurred during rounds which impacted the care of a patient.: |
1-Medication Adjustment Based on Lab Results - A patient's renal function was reviewed, leading to the adjustment of renally-cleared medications (e.g., lowering the dose of vancomycin or discontinuing metformin), minimizing the risk of toxicity. ?2-Discontinuation of Unnecessary Medications - Based on clinical improvement and pharmacist input, a proton pump inhibitor and an opioid were discontinued, reducing the risk of adverse effects such as C. difficile infection and constipation. ?3-Initiation of Targeted Therapy - After reviewing recent cultures and sensitivities, broad-spectrum antibiotics were de-escalated to targeted therapy, promoting antimicrobial stewardship and reducing resistance risk. |
Interprofessional Exposure (SLO 6) Option 1
| Date: | 04/01/2025 |
| Rotation Type: | IPPE Institutional/Hospital Practice |
| Comments: | Interprofessional Exposure (SLO 6) Option 1 |
| Describe how the pharmacist contributed to rounds. If a pharmacist is not part of the rounding team, describe how the team could have benefited from a pharmacist's direct involvement.: | The clinical pharmacist played a vital role during rounds by providing real-time input on medication management and patient safety. They reviewed each patient's active medication list, identified potential drug interactions and duplicative therapies, and made recommendations to optimize dosing, especially in the context of renal and hepatic function. Their involvement significantly enhanced medication reconciliation, promoted evidence-based therapy, and supported interdisciplinary decision-making. |
| List all professions who were part of the interprofessional rounding team. Is your preceptor involved?: |
-Attending Internist IM Chief Resident ?IM PGY-2 IM PGY-1 Clinical Pharmacist ?Pharmacist Intern Medical Student |
| List at least 3 activities that occurred during rounds which impacted the care of a patient.: |
1-Medication Adjustment Based on Lab Results - A patient's renal function was reviewed, leading to the adjustment of renally-cleared medications (e.g., lowering the dose of vancomycin or discontinuing metformin), minimizing the risk of toxicity. 2-Discontinuation of Unnecessary Medications - Based on clinical improvement and pharmacist input, a proton pump inhibitor and an opioid were discontinued, reducing the risk of adverse effects such as C. difficile infection and constipation. ?3-Initiation of Targeted Therapy - After reviewing recent cultures and sensitivities, broad-spectrum antibiotics were de-escalated to targeted therapy, promoting antimicrobial stewardship and reducing resistance risk. |
Pharmacy Student
Health Record Data Collection (SLO 8) Patient 3 Overview
| Date: | 04/04/2025 |
| Rotation Type: | IPPE Institutional/Hospital Practice |
| Comments: |
Dear Dr. Perez, ?In this section, I will explain the patient's condition on the last day of their hospital admission. Best regards, Ali Afrand Pharmacist Intern |
| Dose: |
Active Medications: ?-Acetaminophen- 650mg -Zofran (ondansetron)- 4mg -Docusate sodium- 100mg ?-Lopressor (metoprolol tartrate)-50mg -Protonix (pantoprazole) - 40mg ?-Famotidine- 20mg ?-Lactated Ringer's IV- 1000ml at 100 ml/hr |
| Family History: | Not pertinent |
| Frequency: |
Active Medications: -Acetaminophen- 650mg- Q6HPRN ?-Zofran (ondansetron)- 4mg- BID PRN -Docusate sodium- 100mg - DAILY ?-Lopressor (metoprolol tartrate)-50mg- BID ?-Protonix (pantoprazole) - 40mg- DAILY ?-Famotidine- 20mg- QPM -Lactated Ringer's IV- 1000ml at 100 ml/hr- DAILY |
| Indication for Use in this patient*: |
Active Medications: -Acetaminophen- Pain relief, fever reduction -Zofran (ondansetron)- Nausea, vomiting prevention -Docusate sodium-Constipation relief ?-Lopressor (metoprolol tartrate)- Hypertension -Protonix (pantoprazole)- ulcer prevention, acid suppression -Famotidine- GERD, peptic ulcer, acid reflux ?-Lactated Ringer's IV fluid/electrolyte solution Hydration, electrolyte replenishment, volume support |
| Medication Name: |
Active Medications: -Acetaminophen ?-Zofran (ondansetron) ?-Docusate sodium -Lopressor (metoprolol tartrate) -Protonix (pantoprazole) -Famotidine -Lactated Ringer's IV |
| Past Medical History: | Hypertension (HTN) |
| Reason for Admission: | A 48-year-old female presented to the ED four days ago with a chief complaint of abdominal pain. She underwent evaluation and was admitted for further management. During her admission, significantly elevated pancreatic enzyme levels were noted, and she was diagnosed with acute pancreatitis. One notable risk factor identified was the use of Ozempic, which she had started approximately one month prior to symptom onset. Treatment for acute pancreatitis was initiated, and her symptoms, along with clinical findings and imaging results, have guided her ongoing care. She has been closely monitored throughout her hospital stay, and supportive treatment continues with follow-up from the appropriate specialty teams. |
| Recommended labs, vitals, and/or disease symptoms to monitor for this medication**: |
-On the last day of admission, all laboratory results were within normal limits. -The patient reports no pain or discomfort at this time. -It is strongly recommended that she discontinue Ozempic moving forward. ?-She should monitor her blood pressure regularly. -It is important that she maintains adequate hydration. ?-For follow-up care, she is advised to see her gastroenterologist (GI doctor) |
| Route: |
Active Medications: ?-Acetaminophen- 650mg- PO ?-Zofran (ondansetron)- 4mg- PO ?-Docusate sodium- 100mg- PO -Lopressor (metoprolol tartrate)-50mg- PO ?-Protonix (pantoprazole) - 40mg- IV -Famotidine- 20mg- PO ?-Lactated Ringer's IV- 1000ml at 100 ml/hr- IV |
| Social History: |
Smoking Status: Unknown if the patient has ever used tobacco Marital Status: Single Gender Identity: Female Sexual Orientation: Straight (heterosexual) |
Health Record Data Collection (SLO 8) Patient 3 Overview
| Date: | 04/04/2025 |
| Rotation Type: | IPPE Institutional/Hospital Practice |
| Comments: |
Dear Dr. Perez, ?In this section, I will explain the patient's condition on the last day of their hospital admission. ?Best regards, ?Ali Afrand Pharmacist Intern |
| Dose: |
Active Medications: -Acetaminophen- 650mg? -Zofran (ondansetron)- 4mg -Docusate sodium- 100mg ?-Lopressor (metoprolol tartrate)-50mg ?-Protonix (pantoprazole) - 40mg -Famotidine- 20mg ?-Lactated Ringer's IV- 1000ml at 100 ml/hr |
| Family History: | Not pertinent |
| Frequency: |
Active Medications: ?-Acetaminophen- 650mg- Q6HPRN -Zofran (ondansetron)- 4mg- BID PRN ?-Docusate sodium- 100mg - DAILY ?-Lopressor (metoprolol tartrate)-50mg- BID ?-Protonix (pantoprazole) - 40mg- DAILY ?-Famotidine- 20mg- QPM -Lactated Ringer's IV- 1000ml at 100 ml/hr- DAILY |
| Indication for Use in this patient*: |
Active Medications: -Acetaminophen- Pain relief, fever reduction ?-Zofran (ondansetron)- Nausea, vomiting prevention -Docusate sodium-Constipation relief -Lopressor (metoprolol tartrate)- Hypertension -Protonix (pantoprazole)- ulcer prevention, acid suppression -Famotidine- GERD, peptic ulcer, acid reflux ?-Lactated Ringer's IV fluid/electrolyte solution Hydration, electrolyte replenishment, volume support |
| Medication Name: |
Active Medications: ?-Acetaminophen -Zofran (ondansetron) ?-Docusate sodium ?-Lopressor (metoprolol tartrate) -Protonix (pantoprazole) -Famotidine -Lactated Ringer's IV |
| Past Medical History: | Hypertension (HTN) |
| Reason for Admission: | A 48-year-old female presented to the ED four days ago with a chief complaint of abdominal pain. She underwent evaluation and was admitted for further management. During her admission, significantly elevated pancreatic enzyme levels were noted, and she was diagnosed with acute pancreatitis. One notable risk factor identified was the use of Ozempic, which she had started approximately one month prior to symptom onset. Treatment for acute pancreatitis was initiated, and her symptoms, along with clinical findings and imaging results, have guided her ongoing care. She has been closely monitored throughout her hospital stay, and supportive treatment continues with follow-up from the appropriate specialty teams. |
| Recommended labs, vitals, and/or disease symptoms to monitor for this medication**: |
-On the last day of admission, all laboratory results were within normal limits. ?-The patient reports no pain or discomfort at this time. -It is strongly recommended that she discontinue Ozempic moving forward. -She should monitor her blood pressure regularly. ?-It is important that she maintains adequate hydration. -For follow-up care, she is advised to see her gastroenterologist (GI doctor) |
| Route: |
Active Medications: -Acetaminophen- 650mg- PO ?-Zofran (ondansetron)- 4mg- PO -Docusate sodium- 100mg- PO -Lopressor (metoprolol tartrate)-50mg- PO -Protonix (pantoprazole) - 40mg- IV ?-Famotidine- 20mg- PO -Lactated Ringer's IV- 1000ml at 100 ml/hr- IV |
| Social History: |
Smoking Status: Unknown if the patient has ever used tobacco Marital Status: Single ?Gender Identity: Female ?Sexual Orientation: Straight (heterosexual) |
Pharmacy Student
Health Record Data Collection (SLO 8) Patient 2 Overview
| Date: | 04/02/2025 |
| Rotation Type: | IPPE Institutional/Hospital Practice |
| Comments: |
Dear Dr. Perez, ?In this part, I will explain the patient's second day of admission. Best regards, Ali Afrand Pharmacist Intern |
| Dose: |
Active Medications: -Simethicone chewable- 80 mg -Acetaminophen- 1000mg/100ml -Hydralazine- 20mg/ml ?-Tramadol- 50mg -Famotidine- 20mg -MiraLAX- 17 gr -Pantoprazole (Protonix)- 40mg -Metoprolol Tartrate (Lopressor)- 50mg ?-Lactated Ringer's - IV - 1000 mL at 100 mL/hr - for hydration and nutrition |
| Family History: | Not pertinent |
| Frequency: |
Active Medications: ?-Simethicone chewable- Q8H -Acetaminophen- ONE TIME ?-Hydralazine- ONE TIME -Tramadol- Q8HPRN ?-Famotidine- QPM ?-MiraLAX- BID -Pantoprazole (Protonix)- DAILY -Metoprolol Tartrate (Lopressor)- BID -Lactated Ringer's - IV - 1000 mL at 100 mL/hr - for hydration and nutrition |
| Indication for Use in this patient*: |
Active Medications: ?-Simethicone chewable - for gas relief -Acetaminophen - for pain or fever -Hydralazine - for blood pressure control ?-Tramadol - for pain management -Famotidine - for acid reduction -MiraLAX - for constipation ?-Pantoprazole (Protonix) - for acid suppression -Metoprolol Tartrate (Lopressor) - for blood pressure control -Lactated Ringer's - IV - 1000 mL at 100 mL/hr - for hydration and nutrition |
| Medication Name: |
Active Medications: ?-Simethicone chewable -Acetaminophen -Hydralazine ?-Tramadol ?-Famotidine ?-MiraLAX -Pantoprazole (Protonix) -Metoprolol Tartrate (Lopressor) -Lactated Ringers- Serum IV- 1000 ml- 100ml/HR |
| Past Medical History: | Essential Hypertension (HTN) |
| Reason for Admission: | A 48-year-old female presented to the ED with abdominal pain radiating to the back, Imaging and labs suggested gallstone pancreatitis, with elevated lipase levels. She was admitted to the internal medicine service, |
| Recommended labs, vitals, and/or disease symptoms to monitor for this medication**: |
Labs Ordered: ?CBC with Differential Pancreatic Enzymes Liver Enzymes Kidney Function Tests ?Electrolytes Blood Glucose Rationale: Due to the patient's symptoms suggestive of pancreatitis, it is important to evaluate pancreatic enzyme levels. Additionally, since the patient is experiencing constipation and requires IV fluid therapy, monitoring her electrolyte levels, such as sodium (Na) and potassium (K) is necessary. ?Note: All laboratory data and vital signs are attached. |
| Route: |
Active Medications: ?-Simethicone chewable- PO ?-Acetaminophen- IV -Hydralazine- IV -Tramadol- PO -Famotidine- PO -MiraLAX- PO -Pantoprazole (Protonix)- IV ?-Metoprolol Tartrate (Lopressor)- PO ?-Lactated Ringer's - IV - 1000 mL at 100 mL/hr - for hydration and nutrition |
| Social History: |
Smoking Status: Unknown if the patient has ever used tobacco Marital Status: Single Gender Identity: Female Sexual Orientation: Straight (heterosexual) |
Pharmacy Student
Pharmacy Student
Health Record Data Collection (SLO 8) Patient 1 Overview
| Date: | 03/30/2025 |
| Rotation Type: | IPPE Institutional/Hospital Practice |
| Comments: |
Dear Dr. Perez, For this assignment, I have chosen one patient and followed her from the first day of admission until her discharge from the hospital. In this part, I will provide information from her first day in the Emergency Department before she was transferred to the Internal Medicine floor. Best regards,? Ali Afrand Pharmacist Intern |
| Dose: |
-Home Medications: ?. Metoprolol Tartrate 50 mg PO daily - for BP control . Ozempic 0.25 mg SC weekly - for weight loss -----------------------------------------------------Medications Administered in the ED: . Famotidine 20 mg IV - for abdominal pain . (Toradol) 30 mg IV - for pain control (NSAID) ?. Metoprolol Tartrate 50 mg PO - for blood pressure control |
| Family History: | - Not pertinent |
| Frequency: |
-Home Medications: ?. Metoprolol Tartrate 50 mg PO daily - for BP control . Ozempic 0.25 mg SC weekly - for weight loss ------------------------------------------------------?- Medications Administered in the ED: ?. Famotidine 20 mg IV - for abdominal pain ?. Ketorolac (Toradol) 30 mg IV - for pain control (NSAID) ?. Metoprolol Tartrate 50 mg PO - for blood pressure control |
| Indication for Use in this patient*: |
-Home Medications: . Metoprolol Tartrate 50 mg PO daily - for BP control ?. Ozempic 0.25 mg SC weekly - for weight loss ?------------------------------------------------------?Medications Administered in the ED: ?. Famotidine 20 mg IV - for abdominal pain ?. Ketorolac (Toradol) 30 mg IV - for pain control (NSAID) ?. Metoprolol Tartrate 50 mg PO - for blood pressure control |
| Medication Name: |
-Home Medications: ?. Metoprolol Tartrate 50 mg PO daily - for BP control ?. Ozempic 0.25 mg SC weekly - for weight loss ------------------------------------------------------- Medications Administered in the ED: ?. Famotidine 20 mg IV - for abdominal pain . Ketorolac (Toradol) 30 mg IV - for pain control (NSAID) ?. Metoprolol Tartrate 50 mg PO - for blood pressure control |
| Past Medical History: | - Hypertension (HTN) |
| Reason for Admission: |
C.C.: Abdominal pain ?- A 48-year-old white female presents to the ED as a walk-in with complaints of epigastric abdominal pain that started four days ago. |
| Recommended labs, vitals, and/or disease symptoms to monitor for this medication**: |
- Keep patient NPO ?- Consult Gastroenterology (GI) ?- Discontinue Ozempic - Admit patient to the Internal Medicine (IM) ward for further assessment ?- Monitor blood pressure regularly - Provide patient with safety information during hospital stay |
| Route: |
-Home Medications: . Metoprolol Tartrate 50 mg PO daily - for BP control ?. Ozempic 0.25 mg SC weekly - for weight loss ?----------------------------------------------------- - Medications Administered in the ED: ?. Famotidine 20 mg IV - for abdominal pain ?. Ketorolac (Toradol) 30 mg IV - for pain control (NSAID) ?. Metoprolol Tartrate 50 mg PO - for blood pressure control |
| Social History: |
- Smoking Status: Unknown if the patient has ever used tobacco ?- Marital Status: Single ?-?Gender Identity: Female - Sexual Orientation: Straight (heterosexual) |
SHARE